Michael J. Valentino - 14 Jun 2021 Form 4 Insider Report for PLx Pharma Inc.

Role
Executive Chairman, Director
Signature
/s/ Natasha Giordano, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
14 Jun 2021
Net transactions value
+$99,870
Form type
4
Filing time
15 Jun 2021, 16:47:06 UTC
Next filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLXPQ Common Stock Purchase $14,928 +1,200 +0.25% $12.44 487,890 14 Jun 2021 Direct
transaction PLXPQ Common Stock Purchase $4,978 +400 +0.08% $12.44 488,290 14 Jun 2021 Direct
transaction PLXPQ Common Stock Purchase $1,245 +100 +0.02% $12.45 488,390 14 Jun 2021 Direct
transaction PLXPQ Common Stock Purchase $1,246 +100 +0.02% $12.46 488,490 14 Jun 2021 Direct
transaction PLXPQ Common Stock Purchase $7,482 +600 +0.12% $12.47 489,090 14 Jun 2021 Direct
transaction PLXPQ Common Stock Purchase $3,742 +300 +0.06% $12.47 489,390 14 Jun 2021 Direct
transaction PLXPQ Common Stock Purchase $1,248 +100 +0.02% $12.48 489,490 14 Jun 2021 Direct
transaction PLXPQ Common Stock Purchase $63,500 +5,080 +1% $12.50 494,570 14 Jun 2021 Direct
transaction PLXPQ Common Stock Purchase $1,501 +120 +0.02% $12.50 494,690 14 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.